L&S Knock-Out NVJP/ DE000LX3G5S5 /
30/05/2024 8:12:03 | Diferencia-0.060 | Bid30/05/2024 | Ask30/05/2024 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.190EUR | -24.00% | 0.190 Volumen de oferta: 11,000 |
0.220 Tamaño/ Volumen/ Formato de Ask: 11,000 |
UMICORE S.A. | 16.3547 EUR | 31/12/2078 | Call |
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página